- Cell Cycle/Checkpoint
- Cyclooxygenase (COX) Inhibitors
- Cytoskeletal Signaling
- DNA Damage/DNA Repair
- DNA/RNA Synthesis
- G-protein Coupled Receptors and 7-TM Receptors
- GPCR/G-Protein
- Immunology and Inflammation
- Inhibitors
- JNK
- MAPK
- Microbiology/Virology
- Neuroscience
- PI3K
- PI3K/Akt/mTOR Signaling
- Prostaglandin Receptor
- ROS
- Stem Cell and Derivatives
- Stem Cells
- gsk-3
- p38 MAPK
Product Information
Dehydroglyasperin D exhibits anticancer, anti-inflammatory, anti-obesity, antioxidant and anti-aldose reductase effects, it inhibits the proliferation of HT-29 human colorectal cancer cells through direct interaction with phosphatidylinositol 3-kinase; it also mediates suppression of both COX-2 expression and the MLK3 signalling pathway through direct binding and inhibition of MLK3. Dehydroglyasperin D shows strong ferric reducing activities and effectively scavenged DPPH, ABTS(+), and singlet oxygen radicals.
Chemical properties
Technical inquiry about: TM-TMA0291 Dehydroglyasperin D
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
